Abstract:ID 129098 Poster Board 565 Glucagon-like peptide-1 (GLP-1) is considered as an important gut hormone regulating blood glucose homeostasis. Previous studies have demonstrated that fructo-oligosaccharides (FOS), prebiotics beneficial for treatment of diabetes mellitus, exert the anti-inflammatory and barrier function-enhacing effects in intestinal epithelial cells. However, effects of FOS on GLP-1 secretion in enteroendocrine cells and their underlying mechanisms have never been investigated. This study aimed to investigate the effect of FOS on GLP-1 secretion in enteroendocrine cells and potential mechanisms underlying the observed effect. Two enteroendocrine cells were evaluated for the effect of FOS on GLP-1 release analyzed by ELISA including NCI-H716 and STC-1 cells. Incubation of NCI-H716 cells with FOS at 100 μg/mL for 2 h and 24 h had no effect on glucose-induced GLP-1 release. High glucose and metformin, used as positive controls, also failed to induce GLP-1 release in NCI-H716 cells, indicating NCI-H716 cells were resistant to GLP-1 inducers. In contrast, GLP-1 release from STC-1 cells was signitifantly stimulated by glucose after 24 h of incubation. FOS (100 μg/mL) further increased the GLP-1 release induced by glucose, indicating that FOS had the potentiating effect on glucose-induced GLP-1 release in STC-1 cells. Importantly, pretreatment of STC-1 cells with 2',5'-dideoxyadenosine, an adenylate cyclase (AC) inhibitor, but not U-73122, a phospholipase C (PLC) inhibitor, significantly blunted the effect of FOS on potentiating GLP-release. Both 2',5'-dideoxyadenosine and U-73122 had no effect on basal GLP-1 secretion and STC-1 cell viability measured by MTT assays. Our data indicate that FOS potentiates the glucose-induced GLP-1 release from STC-1 enteroendocrine cells by mechanisms involving AC possibly through stimulation of a G-protein-coupled receptor-AC pathway. Further studies on cellular and molecular mechanisms of FOS-induced GLP-1 release may lead to the development of novel altenative approaches for treatment of diabetes mellitus. This project was supported by Faculty of Medicine Ramathibodi Hospital, Mahidol University and the NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation (grant number B05F650041).

Mechanism of fructo-oligosaccharides on potentiating GLP-1 release from enteroendocrine cells

Fructo-oligosaccharide Intensifies Visceral Hypersensitivity and Intestinal Inflammation in a Stress-Induced Irritable Bowel Syndrome Mouse Model

Oligofructose as an adjunct in treatment of diabetes in NOD mice

Fructooligosaccharides from Cynoglossum tubiflorus: Effect of the molecular size on their antidiabetic activity in high-fat diet and alloxan induced diabetic rats

Metabolism of Fructooligosaccharides in Lactobacillus plantarum ST-III via Differential Gene Transcription and Alteration of Cell Membrane Fluidity

Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2

Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2

Transformation of sugarcane molasses into fructooligosaccharides with enhanced prebiotic activity using whole-cell biocatalysts from Aureobasidium pullulans FRR 5284 and an invertase-deficient Saccharomyces cerevisiae 1403-7A

Fructo-oligosaccharide effects on blood glucose: an overview

Fructooligosaccharides benefits on glucose homeostasis upon high-fat diet feeding require type 2 conventional dendritic cells

Integrated Multi-Omics Analysis Reveals Differential Effects of Fructo-Oligosaccharides (FOS) Supplementation on the Human Gut Ecosystem

Dose-dependent effects of xylooligosaccharides on glycemic regulation with L. rhamnosus CCFM1060 in diabetic mice

Metagenomic Insights into the Effects of Fructooligosaccharides (FOS) on the Composition of Luminal and Mucosal Microbiota in C57BL/6J Mice, Especially the Bifidobacterium Composition

Hypoglycemic property of acidic polysaccharide extracted from Saccharina japonica and its potential mechanism

Agriophyllum Oligosaccharides Ameliorate Diabetic Insulin Resistance Through INS-R/IRS/Glut4-Mediated Insulin Pathway in db/db Mice and MIN6 Cells

Dietary Intake of Fructooligosaccharides Protects against Metabolic Derangements Evoked by Chronic Exposure to Fructose or Galactose in Rats

Polygonatum cyrtonema Hua Polysaccharide Promotes GLP-1 Secretion from Enteroendocrine L-Cells through Sweet Taste Receptor-Mediated cAMP Signaling

Effect of xylo-oligosaccharides and β-glucan on gut microbiota and short chain fatty acid in diabetic rats

Nutrient Combinations Sensed by L-Cell Receptors Potentiate GLP-1 Secretion

Oral administration of osteocalcin improves glucose utilization by stimulating glucagon-like peptide-1 secretion

Fructooligosaccharides and galactooligosaccharides improve hepatic steatosis via gut microbiota-brain axis modulation